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ABSTRACT 
Primary cardiac angiosarcoma is a very rare disease with a poor prognosis. We report a case of a patient with a 
primary cardiac angiosarcoma who presented with cardiac tamponade; the angiosarcoma was successfully resected 
surgically. (Korean Circ J 2010;40:86-89) 
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Introduction 
 
Primary cardiac tumors are rare. Twenty-five percent 
of primary cardiac tumors are malignant. The most com-
mon type of primary malignant cardiac tumor is an an-
giosarcoma, followed by leiomyosarcomas, rhabdomyo-
sarcomas, and osteosarcomas.   
The prognosis of primary malignant cardiac tumors 
remains poor. The prognosis of angiosarcomas is worse 
than that of other histologic types. High mortality rates 
of angiosarcomas are attributed to the rapid local re-
lapse and high incidence of systemic metastasis. 
We report a patient with a primary cardiac anigosar-
coma who presented with a massive pericardial effusion 
and was treated surgically. 
 
Case 
 
A 63-year-old man was admitted for chest discom-
fort, orthopnea, and dyspnea on exertion lasting 5 days. 
His initial vital signs included a blood pressure of 100/ 
60 mmHg, a pulse rate of 80 beats/min, a respiratory 
rate of 20/min, and a body temperature of 36.6℃. 
The jugular vein was engorged, but no hepato-
megaly or audible cardiac murmurs were detected. The 
laboratory tests revealed the following: a hemoglobin, 
11.3 g/dL; hematocrit, 35.3%; white blood cell (WBC) 
count, 9,550/mm
3; platelet count, 254,000/mm
3; blood 
urea nitrogen, 14 mg/dL; serum creatinine, 1.0 mg/dL; 
alanine aminotransferase, 58 IU/L; aspartate aminotrans-
ferase, 40 IU/L; total bilirubin, 0.9 mg/dL; glucose, 
166 mg/dL; lactate dehydrogenase, 444 IU/L; protein, 
6.4 g/dL; and albumin, 3.7 g/dL. Chest radiography 
showed an increased cardiac silhouette with a round, 
flask-like appearance (Fig. 1). Computed tomography 
and transthoracic echocardiography showed a large in-
homogeneous and focally-enhancing mass in the right 
atrium, and a massive amount of pericardial and right 
pleural effusion (Fig. 2).  
While in the emergency room, the blood pressure 
dropped to 80/54 mmHg and the pulse rate increased 
to 101 beats/min; the patient complained of severe dy-
spnea and chest pain, suggesting cardiac tamponade. 
An emergency pericardiocentesis and drainage was per-
formed. The pericardial effusion was blood-like in co-
lor; an effusion analysis showed the following: hemo-
globin, 11.9 g/dL; red blood cell (RBC) count, 2.95×
10
6/ mm
3; WBC, 15,210/mm
3 (lymphocytes, 68%; neu-
trophils, 23%), glucose, 109 mg/dL; lactate dehydro-
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genase, 591 IU/L; and protein, 5.6 g/dL. The initial 
drainage of the pericardial effusion was 800 mL. There 
were no malignant cells in the pericardial effusion cy-
tology. The chest pain and dyspnea were improved im-
mediately after the pericardiocentesis. Transesophageal 
echocardiography showed a 5.5×5 cm mass without 
invasion of the inferior and superior vena cava (Fig. 3). 
On hospital day (HD) 5, surgery was performed. Af-
ter the mass was resected, the right atrium was repair-
ed with a bovine pericardial patch. The mass was close 
to the tricuspid valve (only 2 mm from the resection 
margin). On HD 7, the patient was transferred to the 
general ward and on HD 13 he was discharged. The 
patient was scheduled to receive adjuvant radiotherapy 
and chemotherapy. 
At the time of biopsy, a 6.8×6.5×2.5 cm gray-
brown protruding endocardial mass was noted in the 
right atrial chamber. The pericardium was spared of 
malignant cells. The cut surface was diffusely hemor-
rhagic with a gray-white solid portion. The tumor was 
comprised of oval-to-spindle cells with intracytopla-
smic RBCs. There were frequent mitoses (> 10/10 HPF). 
The tumor cells were positive for CD34 immunohisto-
chemical staining with confirmed primary cardiac an-
giosarcoma (Fig. 4).  
 
Discussion 
 
Primary cardiac tumors are very rare. Secondary or 
metastatic cardiac tumors are 20-40 times more com-
mon than primary cardiac tumors, such as lymphomas, 
leukemias, malignant melanomas, and lung and breast 
cancers. The incidence of primary cardiac tumors is 
approximately 0.02% based upon the data of 22 large 
autopsy series.
1)2) Twenty-five percent of primary cardiac 
tumors are malignant.
3)  
Dyspnea on exertion is the most common symptom 
of primary cardiac sarcomas at the time of presenta-
tion (79%), followed by non-specific chest pain (38%), 
cough (21%), paroxysmal nocturnal dyspnea (12%), he-
moptysis (12%), embolic events (9%), and fever (9%).
4) 
Several diagnostic tools for primary cardiac tumors 
are available. Echocardiography is a screening modality, 
showing tumor size, location, mobility, attachment, and 
transesophageal echocardiography better depicts the 
posterior wall of the left atrium, atrial septum, right 
heart, and descending aorta. Diagnostic sensitivities of 
Fig. 1. Round, increased cardiac silhouette and right costoph-
renic angle blunting on chest radiography. 
Fig. 3. Transesophageal echocardiography shows a primary car-
diac mass without involvement of the inferior and superior vena
cava. IVC: inferior vena cava, SVC: superior vena cava, RA: ri-
ght atrium, LA: left atrium. 
Fig. 2. Chest CT (A) and transthoracic echocardiography (B) shows a large and inhomogeneous, enhancing mass in the right atrium
(arrow) and a massive amount of pericardial and right pleural effusion. 
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transthoracic and transesophageal echocardiography are 
93.3% and 96%, respectively.
5) Cardiac computed to-
mography and magnetic resonance imaging can reveal 
infiltrative growth and the extracardiac extent of sarco-
mas, which are criteria that help distinguish benign from 
malignant lesions and assess respectability.
6)7) Coronary 
arteriography may demonstrate tumor blood supply and 
distortion of coronary anatomy, but is not essential in 
diagnosis.
8) 
The currently established treatment of cardiac sar-
comas is limited to surgical resection. Complete surgical 
resection is the most important prognostic factor.
9) Other 
prognostic factors include left-sided lesion, absence of 
necroses or metastases, and low mitotic count. Age, gen-
der, and histologic grade do not appear to affect the 
prognosis.
4) Causes of death were metastasis or heart 
failure in two case reports.
10)11) 
Llombart-Cussac et al.
12) reported that survival of 
patients with primary cardiac angiosarcomas who un-
derwent complete resection is 22 months, while those 
who underwent incomplete resection is 7 months in. 
Alvarez et al.
13) reported that the mean overall survival 
in patients with primary cardiac angiosarcomas was 5 
months and on subgroup analysis, survival was 3-12 
months in patients who underwent surgery plus ad-
juvant treatment, whereas 5 days to 7 months in those 
who underwent surgery only. However, subsequent stu-
dies have failed to show the survival benefit of adju-
vant treatment.
9)14) Heart and lung transplantation has 
been attempted, but limited experience resulted in poor 
outcome due to local recurrence and metastasis post-
operatively.
15)  
This patient presented with a locally advanced tumor 
with cardiac tamponade without evidence of metasta-
sis. Although the tumor was close to the tricuspid valve, 
it was totally resected with a narrow, but clear margin 
on microscopic exam. We expected a survival benefit 
for this patient from adjuvant treatment following com-
plete surgical resection. On day 30 post-operatively, the 
patient was readmitted for concurrent chemo-radio-
therapy. Radiotherapy was planned for a total dose of 
radiation of 45 Gray in 25 fractions; however, the pa-
tient refused further radiotherapy and chemotherapy 
after four cycles of radiotherapy. The patient has sur-
vived for 4 months after diagnosis. He is attending our 
hospital’s outpatient department.   
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Fig. 4. A: a resected protruding mass (6.8×6.5×2.5 cm) into the right atrial chamber is present at the atrial wall. B: the cut surface is
diffusely hemorrhagic with a gray-white fleshy solid portion. C: the tumor is composed of oval-to-spindle cells with intracytoplasmic red
blood cells. There are frequent mitoses (> 10/10 HPF). D: the tumor cells are positive for CD34 immunohistochemical staining.  
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